Phase IA/IB evaluation of mammalian cell-derived glycosylated recombinant human interleukin (SIGOSIX) before and after cytotoxic chemotherapy. Ann N Y Acad Sci 1995 Jul 21;762:359-60
Date
07/21/1995Pubmed ID
7668536DOI
10.1111/j.1749-6632.1995.tb32340.xScopus ID
2-s2.0-0029144651 (requires institutional sign-in at Scopus site)Author List
Ritch PS, Keever C, Schiller J, Rivkin S, Witt PL, Grossberg SE, Truitt RL, Burris H, von Hoff DD, Vaickus LAuthor
Robert L. Truitt PhD Emeritus Professor in the Pediatrics department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Antineoplastic AgentsDrug Administration Schedule
Glycosylation
Humans
Interleukin-6
Neoplasms
Recombinant Proteins
